The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| INTELLIA THERAPEUTICS INC | COM | 45826J105 | 23,697 | 1,615,321 | SH | SOLE | 1,615,321 | 0 | 0 | ||
| SNAP INC | CL A | 83304A106 | 2,452 | 150,160 | SH | SOLE | 0 | 0 | 150,160 | ||
| SYNLOGIC INC | COM | 87166L100 | 6,842 | 2,651,963 | SH | SOLE | 2,651,963 | 0 | 0 | ||
| SPERO THERAPEUTICS INC | COM | 84833T103 | 13,247 | 1,376,968 | SH | SOLE | 1,376,968 | 0 | 0 | ||
| UNUM THERAPEUTICS INC | COM | 903214104 | 2,420 | 3,361,535 | SH | SOLE | 3,361,535 | 0 | 0 | ||
| SURFACE ONCOLOGY INC | COM | 86877M209 | 8,733 | 4,645,453 | SH | SOLE | 4,645,453 | 0 | 0 | ||